Sucralfate and Dymista drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sucralfate (sucralfate) and Dymista (azelastine hydrochloride; fluticasone propionate). Common drug interactions include maculopathy among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Sucralfate and Dymista. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.

What is Dymista?

Dymista has active ingredients of azelastine hydrochloride; fluticasone propionate. It is often used in allergies. eHealthMe is studying from 4,407 Dymista users. Check the latest studies of Dymista.

On Jul, 13, 2026

43 people who take Sucralfate and Dymista together, and have interactions are studied.

Sucralfate and Dymista drug interactions.

What are the common drug interactions of Sucralfate and Dymista, by gender? *:

female:

Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Bacterial infection
Chest injury
Dehydration (dryness resulting from the removal of water)
Discomfort
Duodenal stenosis (block of the first part of the small intestine)
Dysphonia (speech disorder attributable to a disorder of phonation)
Eye irritation
Fungal infection
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)

male:

Pneumonia
Abscess limb (limb infection)
Nephrolithiasis (calculi in the kidneys)
Pain
Scrotal abscess (pus in scrotum)
Tenderness (pain or discomfort when an affected area is touched)
Testicular abscess (pus in testes)
Tooth abscess (pus formation in tooth)
Anal abscess
Blood glucose decreased

What are the common drug interactions of Sucralfate and Dymista, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Decreased appetite
Fibromyalgia (a long-term condition which causes pain all over the body)
Gastritis (inflammation of stomach)
Haematochezia (passage of stools containing blood)
Headache (pain in head)
Hypoaesthesia (reduced sense of touch or sensation)
Migraine (headache)
Nausea (feeling of having an urge to vomit)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

40-49:

Abdominal pain
Arthralgia (joint pain)
Asthenia (weakness)
Blood pressure increased
Chest discomfort
Chills (felling of cold)
Decreased immune responsiveness
Defaecation urgency (a sudden compelling urge to defecate)
Diarrhoea
Fatigue (feeling of tiredness)

50-59:

Generalised anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry)
Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Diarrhoea
Eye irritation
Malaise (a feeling of general discomfort or uneasiness)
Pruritus (severe itching of the skin)
Secretion discharge
Swelling

60+:

Abdominal distension
Bacterial infection
Infusion site erythema (reddening of the skin at infusion site)
Infusion site pain
Infusion site swelling
Insomnia (sleeplessness)
Malignant melanoma (skin cancer rises from melancytes)
Multiple allergies (allergy to multiple agents)
Oesophageal candidiasis (fungal infection of oesophagus)
Pain

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 25.58%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 20.93%
Asthma: 7 people, 16.28%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 11.63%
Immunodeficiency Common Variable: 4 people, 9.30%
Type 2 Diabetes: 3 people, 6.98%
Pain: 3 people, 6.98%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 6.98%
Constipation: 3 people, 6.98%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Sucralfate and Dymista?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously